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Debating DAP12
 
Mice that lack the adaptor protein DAP12 
defy deadly bacterial infections, according 
to Turnbull and colleagues on page
363. DAP12-deficient mice developed a 
muted inflammatory response, allowing 
the immune system to clear the bacteria 
without triggering septic shock.
DAP12 is a transmembrane adaptor 
protein that is associated with an array of 
DAP12-deficient mice (dotted 
line) are resistant to a lethal endo-
toxin challenge.
 
activating receptors on the surface of immune, brain, and bone cells. DAP12 is 
required for the development of bone-resorbing osteoclasts, but its role in immune 
cells is less clear. Some studies have suggested that DAP12-dependent signals 
amplify cellular activation and inflammatory cytokine production in response to 
invading microbes, but others argue that DAP12 signaling inhibits these functions.
Turnbull et al. now weigh in on this debate by showing that mice lacking 
DAP12 can fend off a systemic bacterial infection without producing shock-
inducing amounts of inflammatory cytokines such as tumor necrosis factor, 
suggesting that DAP12 signaling normally amplifies inflammation. These data 
are consistent with their previous studies in which blocking the DAP12-associated 
receptor TREM-1, which is expressed on granulocytes and monocytes, 
protected mice against septic shock.
The resistance of the DAP12-deficient mice to bacterial infections is 
consistent with the situation in humans. Humans lacking DAP12 develop a 
lethal bone wasting and neurodegenerative disease, but do not seem to be 
more susceptible to infections. Thus far, the benefit of expressing DAP12 on 
immune cells that respond to bacterial infections remains a mystery. 
 
TIM-2 tones down Th2
 
The TIM (T cell immunoglobulin mucin) proteins are emerging as critical
regulators of T helper (Th) cell responses and as potential susceptibility factors
for the development of allergic and autoimmune diseases. On page 437,
Chakravarti and colleagues add to the developing TIM story by showing that
TIM-2 is preferentially expressed on differentiated Th2 cells and inhibits
their expansion and function. These molecules, according to senior author
Vijay Kuchroo, are not only critical modulators of the CD4
 
 
 
 Th cell
response, but are the first reliable markers of differentiated Th cell subsets.
The 
 
TIM
 
 genes were originally identified as residents of a chromo-
somal locus that conferred susceptibility to asthma. Since then, this group
has shown that TIM3 is expressed exclusively on polarized Th1 cells and
dampens their activation. They now show an analogous function for
TIM-2 on Th2 cells. Blocking TIM-2 increased the production of Th2
cytokines and protected mice against Th1-driven experimental auto-
immune encephalomyelitis, suggesting that TIM-2 normally inhibits
excessive activation of Th2 cells.
Although the signals in T cells that drive the expression of TIM2 and
TIM3 are not known, their exclusive expression on polarized Th cells
(not simply activated T cells) suggests that TIM2 and TIM3 expression
may be driven by Th2- and Th1-specific transcription factors, respec-
tively. The structure of the TIM molecules, which most closely resembles
the adhesion molecule MAdCAM, suggests that these proteins may also
affect lymphocyte trafficking. 
 
Bone cells unite
 
Bone-resorbing osteoclasts can’t pull together
in the absence of dendritic cell–specific trans-
membrane protein (DC-STAMP), according
to new data from Yagi and colleagues (page
345). Without this receptor, osteoclast
precursor cells cannot fuse with one another.
The failure to fuse cripples the bone resorbing
function of the cells, causing osteopetrosis
(increased bone mass).
DC-STAMP is a seven-transmembrane–
spanning receptor that was originally isolated
from dendritic cells (DCs). The ligand for
DC-STAMP and its function on DCs are un-
known, but this receptor was recently found
on osteoclasts and shown to be required for
these cells to develop from their macrophage
precursors.
Yagi and colleagues now refine these
data by showing that multinucleated osteo-
clasts were completely absent in the bones of
mice lacking DC-STAMP, although osteoclast
development was intact. The DC-STAMP–
deficient mice suffered from mild osteopetro-
sis, as mononucleated osteoclasts can still resorb
bone. Whether DC-STAMP triggers fusion
directly or triggers the expression of other
fusion-inducing receptors remains to be
determined.
The absence of DC-STAMP also in-
hibited the formation of foreign body giant
cells—products of macrophage fusion that
dispose of foreign bodies in tissues. Although
the mechanism is not yet known, DC-
STAMP may function as a fusion coreceptor
in a fashion analogous to the fusion of HIV
with target cells, which depends on seven-
transmembrane–spanning chemokine receptors
(see commentary from Vignery, on page
337). 
Fusion of preosteoclasts to generate multinucleated 
osteoclasts is defective in the absence of DC-STAMP 
(right).
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